NZ336376A - Enzymatic resolution of benzodiazepine-acetic acid esters (3-oxo-2,3,4,5-1H-tetrahydro-1,4-benzodiazepine-2-acetic acid) with a lipase from Candida Antarctica - Google Patents
Enzymatic resolution of benzodiazepine-acetic acid esters (3-oxo-2,3,4,5-1H-tetrahydro-1,4-benzodiazepine-2-acetic acid) with a lipase from Candida AntarcticaInfo
- Publication number
- NZ336376A NZ336376A NZ336376A NZ33637697A NZ336376A NZ 336376 A NZ336376 A NZ 336376A NZ 336376 A NZ336376 A NZ 336376A NZ 33637697 A NZ33637697 A NZ 33637697A NZ 336376 A NZ336376 A NZ 336376A
- Authority
- NZ
- New Zealand
- Prior art keywords
- benzodiazepine
- acetic acid
- tetrahydro
- oxo
- lipase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Abstract
A process for preparing a compound of the formula (I): wherein X is H, halogen, CO2R3, OR4, COR5, or a fibrinogen or vitronectin antagonist side chain; R2 is C1-6alkyl, optionally substituted by Ar, Het or C1-6cycloalkyl; R3 is C1-6alkyl or benzyl; R4 is Cl-6alkyl, COR3 or benzyl; R5 is 4,4'-bipiperidin-1-yl, (1' -benzyloxycarbonyl)-4 ,4' -bipiiperidin-l-yl, or (l'-t- butoxycarbonyl)-4,4'-bipiperidin-1 -yl; which comprises: a) treating a compound of the formula (II): wherein R1 is C1-20alkyl or C3-20alkenyl, optionally substituted by Ar, NR2 or NR3+, wherein R is C1-4alkyl; with Candida Antarctica lipase B; b) and separating the resulting 2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2- acetic acid carboxylic acid from the corresponding ester.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3385396P | 1996-12-27 | 1996-12-27 | |
PCT/GB1997/003522 WO1998029561A1 (en) | 1996-12-27 | 1997-12-23 | Enzymatic resolution of benzodiazepine-acetic acid esters with a lipase |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ336376A true NZ336376A (en) | 2000-11-24 |
Family
ID=21872833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ336376A NZ336376A (en) | 1996-12-27 | 1997-12-23 | Enzymatic resolution of benzodiazepine-acetic acid esters (3-oxo-2,3,4,5-1H-tetrahydro-1,4-benzodiazepine-2-acetic acid) with a lipase from Candida Antarctica |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0964928A1 (en) |
JP (1) | JP2001507231A (en) |
KR (1) | KR20000069705A (en) |
CN (1) | CN1246157A (en) |
AR (1) | AR010860A1 (en) |
AU (1) | AU730064B2 (en) |
BR (1) | BR9714099A (en) |
CA (1) | CA2276134A1 (en) |
CO (1) | CO4930272A1 (en) |
HU (1) | HUP0002825A3 (en) |
IL (1) | IL130580A0 (en) |
NO (1) | NO993174D0 (en) |
NZ (1) | NZ336376A (en) |
PL (1) | PL334293A1 (en) |
TR (1) | TR199901487T2 (en) |
WO (1) | WO1998029561A1 (en) |
ZA (1) | ZA9711566B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE258604T1 (en) * | 1998-02-17 | 2004-02-15 | Searle & Co | METHOD FOR THE ENZYMATIC DISSOLUTION OF LACTAMS |
KR100378741B1 (en) * | 2000-06-01 | 2003-04-07 | 에스케이 주식회사 | Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid and counter enantiomeric form of α-substituted heterocyclic carboxyl acid ester thereto using enzyme |
CA2410438A1 (en) * | 2000-06-01 | 2001-12-06 | Sk Corporation | Method for optically resolving a racemic alpha-substituted heterocyclic carboxylic acid using enzyme |
KR100379756B1 (en) * | 2000-10-02 | 2003-04-11 | 한국과학기술연구원 | Resolution of chiral compounds |
US6828119B2 (en) * | 2001-01-04 | 2004-12-07 | Bristol Myers Squibb Company | Enzymatic deprotection of amines and hydroxides |
FR2853327B1 (en) * | 2003-04-04 | 2012-07-27 | Solvay | PROCESS FOR THE PRODUCTION OF ENANTIOPOR BETA-AMINOACID DERIVATIVES AND ENANTIOPA BETA-AMINOACIDIC DERIVATIVES |
KR100650798B1 (en) * | 2004-07-19 | 2006-11-27 | (주)제이코통상 | Process for preparing chiral substituted carboxylic acid |
FR2876102A1 (en) * | 2004-10-04 | 2006-04-07 | Solvay | ENANTIOPUR HETEROCYCLIC COMPOUND |
KR100650797B1 (en) * | 2005-12-12 | 2006-11-27 | (주)케미코월드 | Process for preparing chiral substituted cyclopropane carboxamide |
FR2986804A1 (en) * | 2012-02-09 | 2013-08-16 | Servier Lab | PROCESS FOR THE ENZYMATIC SYNTHESIS OF (7S) 3,4-DIMETHOXYBICYCLO [4.2.0] OCTA-1,3,5-TRIENE 7-CARBOXYLIC ACID OR ITS ESTERS, AND APPLICATION TO THE SYNTHESIS OF IVABRADIN AND IES SALTS |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2190428T3 (en) * | 1991-06-28 | 2003-08-01 | Smithkline Beecham Corp | BIBLICAL FIBRINOGEN ANTAGONISTS. |
WO1994014776A2 (en) * | 1992-12-21 | 1994-07-07 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
MA23420A1 (en) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | BICYCLIC FIBRINOGEN ANTAGONISTS. |
US5529929A (en) * | 1995-06-07 | 1996-06-25 | Seprachem, Inc. | Optical resolution of alkyl 1,4-benzodioxan-2-carboxylates using esterase from serratia marcescens |
-
1997
- 1997-12-23 CN CN97181853A patent/CN1246157A/en active Pending
- 1997-12-23 AR ARP970106167A patent/AR010860A1/en not_active Application Discontinuation
- 1997-12-23 NZ NZ336376A patent/NZ336376A/en unknown
- 1997-12-23 CA CA002276134A patent/CA2276134A1/en not_active Abandoned
- 1997-12-23 IL IL13058097A patent/IL130580A0/en unknown
- 1997-12-23 HU HU0002825A patent/HUP0002825A3/en unknown
- 1997-12-23 JP JP52974298A patent/JP2001507231A/en active Pending
- 1997-12-23 ZA ZA9711566A patent/ZA9711566B/en unknown
- 1997-12-23 PL PL97334293A patent/PL334293A1/en unknown
- 1997-12-23 TR TR1999/01487T patent/TR199901487T2/en unknown
- 1997-12-23 WO PCT/GB1997/003522 patent/WO1998029561A1/en not_active Application Discontinuation
- 1997-12-23 BR BR9714099A patent/BR9714099A/en not_active IP Right Cessation
- 1997-12-23 AU AU53314/98A patent/AU730064B2/en not_active Ceased
- 1997-12-23 EP EP97950309A patent/EP0964928A1/en not_active Withdrawn
- 1997-12-23 KR KR1019997005777A patent/KR20000069705A/en not_active Application Discontinuation
- 1997-12-26 CO CO97075096A patent/CO4930272A1/en unknown
-
1999
- 1999-06-25 NO NO993174A patent/NO993174D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO993174L (en) | 1999-06-25 |
ZA9711566B (en) | 1998-06-29 |
AU730064B2 (en) | 2001-02-22 |
AU5331498A (en) | 1998-07-31 |
BR9714099A (en) | 2000-03-21 |
PL334293A1 (en) | 2000-02-14 |
WO1998029561A1 (en) | 1998-07-09 |
IL130580A0 (en) | 2000-06-01 |
HUP0002825A2 (en) | 2000-12-28 |
EP0964928A1 (en) | 1999-12-22 |
TR199901487T2 (en) | 1999-11-22 |
AR010860A1 (en) | 2000-07-12 |
KR20000069705A (en) | 2000-11-25 |
JP2001507231A (en) | 2001-06-05 |
NO993174D0 (en) | 1999-06-25 |
HUP0002825A3 (en) | 2002-09-30 |
CN1246157A (en) | 2000-03-01 |
CO4930272A1 (en) | 2000-06-27 |
CA2276134A1 (en) | 1998-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY131501A (en) | Process for the prepration of clavulanic acid | |
AU2852595A (en) | Method for preparing intermediate compounds useful in the preparation of dual action inhibitors | |
IL81127A (en) | Process for the stereospecific preparation of pharmaceutical(s)-2-arylpropionic acids by selective hydrolysis of the esters by microbial esterases | |
BG102410A (en) | Fine molecular inhibitors of rotamase enzymic activity | |
MX9705005A (en) | Inhibitors of microsomal triglyceride transfer protein and method. | |
NZ336376A (en) | Enzymatic resolution of benzodiazepine-acetic acid esters (3-oxo-2,3,4,5-1H-tetrahydro-1,4-benzodiazepine-2-acetic acid) with a lipase from Candida Antarctica | |
EE03215B1 (en) | Single Reactor Preparation of 3-Quinolone Carboxylic Acid Derivatives | |
ATE201687T1 (en) | GALANTHAMIN DERIVATIVE, A METHOD FOR THE PRODUCTION THEREOF AND ITS USE AS A MEDICATION | |
DE69500925D1 (en) | METHOD FOR ISOLATING CLAVULANIC ACID AND PHARMACEUTICALLY COMPATIBLE SALTS FROM FERMENTATION BREW FROM STREPTOMYCES SP.P6621 FERM P2804 | |
EP0310072A3 (en) | Non-peptidyl beta-succinamidoacyl aminodiols as anti-hypertensive agents | |
DK0559533T3 (en) | Process for the preparation of beta-lactam derivative and its synthetic intermediate | |
EP0313847A3 (en) | Non-peptidyl alpha-succinamidoacyl aminodiols as anti-hypertensive agents | |
EP0321192A3 (en) | Non-peptidic renin inhibitors | |
MY107567A (en) | A method for the preparation in a non-racemic form of furo (3,4-c) pyridine derivatives. | |
EP0911415A3 (en) | Microbiological manufacture of L-ascorbic acid | |
WO1999021832A3 (en) | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders | |
HUT61262A (en) | Process for reacting hydroxy compound of small molecular mass with carboxylic acid halgenide | |
DE907654T1 (en) | METHOD FOR DE-ESTERIFICATION | |
AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
ES2130392T3 (en) | PROCEDURE FOR THE PREPARATION OF CLAVULANIC ACID. | |
AU2797292A (en) | Pyridine-3-carboxylic acid esters or amides useful as 5-ht3 antagonists | |
GB2244711B (en) | Immobilized enzymes with process for the production of 6-aminopenicillanic acid | |
PL310621A1 (en) | Method of obtaining condensed carbapeneme derivatives | |
ATE358180T1 (en) | METHOD FOR PRODUCING TRIFLUORINE-3(R) HYDROXYBUTTERIC ACID DERIVATIVES | |
DE60001748D1 (en) | METHOD FOR SYNTHESISING BETA LACTAM DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) |